One-liner: “Absci develops generative AI solutions for the biopharmaceutical industry, focusing on creating better biologics for patients more efficiently.”
Company slogan: Creating Drugs at the Speed of Ai
Positioning: “Absci positions itself as a pioneer in generative AI for drug creation, focusing on biologics and differentiating itself through its unique zero-shot AI approach.”
Description: “Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to learn, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed antibodies to wet lab-validated candidates in as little as six weeks. Our vision is to deliver breakthrough therapeutics at the click of a button, for everyone.”
Employees: 185
Website: Visit websiteHeadquarters: “Vancouver, Washington”
Ownership: Public Company
Founded: 2011
Company type: AI company
Use cases: “drug discovery, biologics, antibody design”
Pricing: –
Client sector: biopharmaceutical industry
Business model: partnership and collaboration
Products: Integrated Drug Creation™ platform
Is API available: no
Website title: Biologics Drug Discovery | Absci
Website description: “Absci streamlines biologics drug discovery to develop new therapies for patients, faster, with the data to learn, the AI to create, and the wet lab to validate.”
Linkedin: https://www.linkedin.com/company/absci
Youtube: https://www.youtube.com/c/absci
Instagram: –
Facebook: –
Twitter: https://twitter.com/abscibio
Crunchbase: https://www.crunchbase.com/organization/absci
Email: –